These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23083048)

  • 1. Rituximab in refractory cutaneous polyarteritis.
    Krishnan S; Bhakuni DS; Kartik S
    Int J Rheum Dis; 2012 Oct; 15(5):e127. PubMed ID: 23083048
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission induced by infliximab in a childhood polyarteritis nodosa refractory to conventional immunosuppression and rituximab.
    Campanilho-Marques R; Ramos F; Canhão H; Fonseca JE
    Joint Bone Spine; 2014 May; 81(3):277-8. PubMed ID: 24388782
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa-like cutaneous vasculitis.
    Garcia-Porrua C; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S138. PubMed ID: 14740443
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of polyarteritis nodosa successfully treated by rituximab].
    Sonomoto K; Miyamura T; Watanabe H; Takahama S; Nakamura M; Ando H; Minami R; Yamamoto M; Saito T; Imayama S; Hosokawa C; Suematsu E
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Apr; 31(2):119-23. PubMed ID: 18446015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory anti-synthetase syndrome treated with rituximab.
    Ball EM; Savage EM; Pendleton A
    Rheumatology (Oxford); 2010 May; 49(5):1013. PubMed ID: 20032227
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous polyarteritis nodosa in adult onset Still's disease.
    Mylona E; Vadala C; Papadakos V; Loverdos D; Samarkos M; Skoutelis A
    Eur J Dermatol; 2009; 19(6):621-2. PubMed ID: 19592325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with low-dose weekly methotrexate in a case of undifferentiated spondyloarthropathy coexisting with cutaneous polyarteritis nodosa.
    Queiro R; De Dios JR
    Clin Rheumatol; 2002 Aug; 21(4):304-5. PubMed ID: 12189458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept.
    Valor L; Monteagudo I; de la Torre I; Fernández CG; Montoro M; Longo JL; Carreño L
    Mod Rheumatol; 2014 Jul; 24(4):688-9. PubMed ID: 24981320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory polyarteritis nodosa successfully treated with infliximab.
    Al-Bishri J; le Riche N; Pope JE
    J Rheumatol; 2005 Jul; 32(7):1371-3. PubMed ID: 15996083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous polyarteritis nodosa in a patient with fabry disease.
    Chen HJ; Yang CC; Hsiao CH; Chu CY
    Arch Dermatol; 2008 Jan; 144(1):122-3. PubMed ID: 18209188
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful use of rituximab in recalcitrant skin predominant dermatomyositis.
    Joshi N; Nautiyal A; Davies PG
    J Clin Rheumatol; 2011 Mar; 17(2):111-2. PubMed ID: 21364354
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic orbital inflammation successfully treated using rituximab in a patient with rheumatoid arthritis.
    Ibrahim I; Barton A; Ibrahim A; Ho P
    J Rheumatol; 2012 Jul; 39(7):1485-6. PubMed ID: 22753803
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of rituximab in a patient with lupus nephritis despite low levels of CD19.
    Bacconnier L; Combe B; Canaud B; Morel J
    Rheumatology (Oxford); 2010 Dec; 49(12):2452-3. PubMed ID: 20591832
    [No Abstract]   [Full Text] [Related]  

  • 14. Life-threatening hepatitis C virus-associated polyarteritis nodosa successfully treated by rituximab.
    Néel A; Masseau A; Hervier B; Bossard C; Cacoub P; Pagnoux C; Hamidou MA
    J Clin Rheumatol; 2011 Dec; 17(8):439-41. PubMed ID: 22089995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins as treatment of severe cutaneous polyarteritis nodosa.
    Marie I; Miranda S; Girszyn N; Soubrane JC; Vandhuick T; Levesque H
    Intern Med J; 2012 Apr; 42(4):459-62. PubMed ID: 22498120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome].
    Imai E
    Nihon Jinzo Gakkai Shi; 2012; 54(5):593-7. PubMed ID: 22991838
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous periarteritis nodosa. A case report.
    De Scheerder IK; De Vos LN; Geerts ML; Clement DL
    Int Angiol; 1985; 4(2):211-3. PubMed ID: 2870123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD.
    George L; George B; Gottlieb DJ; Hertzberg M; Fernandez-Peñas P
    Bone Marrow Transplant; 2012 May; 47(5):737-8. PubMed ID: 21785472
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination.
    Ventura F; Antunes H; Brito C; Pardal F; Pereira T; Vieira AP
    Eur J Dermatol; 2009; 19(4):400-1. PubMed ID: 19467971
    [No Abstract]   [Full Text] [Related]  

  • 20. One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare.
    Song IH; Heldmann F; Rudwaleit M; Listing J; Appel H; Haug-Rost I; Braun J; Sieper J
    Ann Rheum Dis; 2013 Feb; 72(2):305-6. PubMed ID: 22887847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.